Sunset Island (SIGO) 10-K 25 Mar 19 2017 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Oct. 31, 2017	Feb. 28, 2019	Apr. 30, 2017
Document And Entity Information
Entity Registrant Name	Sunset Island Group, Inc
Entity Central Index Key	0001689066
Document Type	10-K
Document Period End Date	Oct. 31, 2017
Amendment Flag	false
Current Fiscal Year End Date	--10-31
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	No
Entity Filer Category	Non-accelerated Filer
Entity Common Stock, Shares Outstanding		5,386,771
Entity Public Float			$ 1,023,486
Document Fiscal Year Focus	2017
Document Fiscal Period Focus	FY
Emerging Growth Company	true
Entity Small Business	true
Entity Shell Company	false
Entity Ex Transition Period	false

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($)	Oct. 31, 2017	Oct. 31, 2016
Current Assets
Cash and cash equivalents	$ 24,656	$ 970
Total Current Assets	24,656	970
Deposit	14,000
Total Assets	38,656	970
Current Liabilities
Accounts payable and accrued liabilities	25,817
Dividend payable	46,029
Due to related party	2,885
Total Current Liabilities	74,731
Notes payable - related party	330,200
Total Liabilities	404,931
Commitments and Contingencies (note 8)
Stockholders' Equity (Deficit)
Common Stock, par value $0.0001, 27,000,000 shares authorized (500,000,000 shares authorized at October 31, 2016), 4,871,771 and 50,031,771 shares issued and outstanding, respectively	487	5,003
Additional paid in capital	334,168	5,997
Subscriptions received - shares to be issued	(50,000)
Accumulated deficit	(751,390)	(10,030)
Total Stockholders' Equity (Deficit)	(366,275)	970
Total Liabilities and Stockholders' Equity (Deficit)	38,656	970
Series A Preferred Stock
Stockholders' Equity (Deficit)
Preferred Stock	460
Series B Preferred Stock [Member]
Stockholders' Equity (Deficit)
Preferred Stock
Series C Preferred Stock [Member]
Stockholders' Equity (Deficit)
Preferred Stock

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Nov. 01, 2017	Oct. 31, 2017	Sep. 07, 2017	Aug. 20, 2017	Oct. 31, 2016
Stockholders' Equity (Deficit):
Common Stock, par value		$ 0.0001			$ 0.0001
Common Stock, shares authorized		27,000,000			500,000,000
Common Stock, shares issued	500,000	4,871,771			50,031,771
Common Stock, shares outstanding		4,871,771			50,031,771
Preferred Stock, par value		$ 0.0001			$ 0.0001
Preferred Stock, Shares designated		15,000,000			15,000,000
Series A Preferred Stock
Stockholders' Equity (Deficit):
Preferred Stock, Shares designated		4,600,000		4,600,000	4,600,000
Preferred Stock, shares issued		4,600,000			0
Preferred Stock, shares outstanding		4,600,000			0
Series B Preferred Stock [Member]
Stockholders' Equity (Deficit):
Preferred Stock, Shares designated		8,000,000	8,000,000		8,000,000
Preferred Stock, shares issued		0			0
Preferred Stock, shares outstanding		0			0
Series C Preferred Stock [Member]
Stockholders' Equity (Deficit):
Preferred Stock, Shares designated		500,000			500,000
Preferred Stock, shares issued		0			0
Preferred Stock, shares outstanding		0			0

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	1 Months Ended	12 Months Ended
	Oct. 31, 2016	Oct. 31, 2017
Consolidated Statements Of Operations
Revenue
Operating Expenses
Labor		331,979
Supplies		114,896
General and administrative expenses	30	91,725
Lease		89,622
Officer payroll		38,168
Utilities		17,713
Professional fees	10,000	6,585
Total Operating Expenses	10,030	690,688
Loss from operations	(10,030)	(690,688)
Income tax provision
Net Loss	$ (10,030)	$ (690,688)
Net loss per common share - basic and diluted	$ 0	$ (0.02)
Weighted average number of shares outstanding, basic and diluted	48,183,744	42,368,867

CONSOLIDATED STATEMENTS OF STOC

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)	Series A Preferred Stock	Common Stock	Additional Paid-In Capital	Common Stock Subscription Received	Accumulated Deficit	Total
Beginning Balance, Shares at Sep. 28, 2016
Beginning Balance, Amount at Sep. 28, 2016
Founders' shares, Shares		46,000,000
Founders' shares, Amount		$ 460	(4,600)	4,140
Reverse merger adjustment, Shares		31,771
Reverse merger adjustment, Amount		$ 3	(3)
Common stock issued, Shares		4,000,000
Common stock issued, Amount		$ 400	10,600			11,000
Net loss for the period					(10,030)	(10,030)
Ending Balance, Shares at Oct. 31, 2016		50,031,771
Ending Balance, Amount at Oct. 31, 2016		$ 5,003	5,997		(10,030)	970
Common stock issued, Shares		840,000
Common stock issued, Amount		$ 84	83,916			84,000
Cancellation of the founders' shares in exchange for Series A Preferred stock, Shares	4,600,000	(46,000,000)
Cancellation of the founders' shares in exchange for Series A Preferred stock, Amount	$ 460	$ (4,600)	4,140
Subscriptions received - shares to be issued				50,000		50,000
Contribution			240,115			240,115
Net loss for the period					(690,688)	(690,688)
Declaration of cash dividend					(50,672)	(50,672)
Ending Balance, Shares at Oct. 31, 2017	4,600,000	4,871,771
Ending Balance, Amount at Oct. 31, 2017	$ 460	$ 487	$ 334,168	$ 50,000	$ (751,390)	$ (366,275)

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOW - USD ($)	1 Months Ended	12 Months Ended
	Oct. 31, 2016	Oct. 31, 2017
Cash Flows From Operating Activities:
Net loss	$ (10,030)	$ (690,688)
Change in operating assets and liabilities:
Deposit		(14,000)
Accounts payable and accrued liabilities		25,817
Net Cash Used in Operating Activities	(10,030)	(678,871)
Cash Flows From Financing Activities:
Proceeds from issuance of promissory notes - related party		363,200
Repayment of promissory notes - related party		(33,000)
Proceeds from related party		7,173
Repayment to related party		(4,288)
Proceeds from issuance of common shares	11,000	84,000
Proceeds from stock subscriptions		50,000
Contribution to capital		240,115
Dividends paid		(4,643)
Net Cash Provided by Financing Activities	11,000	702,557
Net change in cash and cash equivalents	970	23,686
Cash and cash equivalents, beginning of period		970
Cash and cash equivalents, end of period	970	24,656
Supplemental cash flow information:
Cash paid for interest
Cash paid for taxes
Non-cash financing transactions:
Cancellation of common stock in exchange for preferred stock		4,600
Common stock issued in reverse merger	$ 3

DESCRIPTION OF BUSINESS

DESCRIPTION OF BUSINESS	12 Months Ended
	Oct. 31, 2017
Notes to Financial Statements
NOTE 1- DESCRIPTION OF BUSINESS	Our Company Sunset Island Group, Inc. is a Colorado corporation. The Company’s principal line of business is the cultivation of medical cannabis. The Company has leased green house space in Northern California that has been approved for cannabis cultivation. The greenhouse is 12,000 square feet; however, the Company is currently operating on approximately 22,000 square feet. This includes the 12,000 square feet of greenhouse space which 10,000 square feet is used for cultivation and 2,000 us used as staging area for planting and harvesting. The Company is currently looking to expand to approximately 154,000 and has been in discussions with or current landlord about expanding to 154,000. Our landlord has over 750,000 square feet of space becoming available shortly. However, the company has recently begun to look at other locations that are nearby the current operations. The Company has agreed to acquire 6,000 square feet of a neighbor’s greenhouse and expects that the agreement to be in place October 1, 2017. The Company is currently in discussions to acquire the neighbors entire 34,000 and is looking an additional 100,000 square feet that is close to the current operations. The Company operates the greenhouses in Monterrey County which allows permits for cannabis cultivation in greenhouses that where existing prior to January 1, 2016. The Company is working on filing its permit with the County. Originally, the County required all permits to be filed prior to August 12, 2017 for operations to continue to operate. However, the county revised the deadline to January 1, 2018. The Company’s landlord has filed its land use permit with the county which covers the Company’s operations and includes our CEO on the permit application. The company has begun its permit process with the County. Until the permit is approved, the Company operates under the medical cannabis laws of the State of California. Additionally, the Company will be consulting and advising clients that operate in the medical marijuana business by providing clients a licensed manufacturing facility to produce products such as oils and edibles. However, the company is waiting for the State of California to finalize the licensing process and requirements for licensed manufacturing facilities before implementing this segment. On January 29, 2018, the Company received its Distributor licenses from the State of California for Adult Use and Medicinal Use. Reverse Merger On October 17, 2016, the Company executed a reverse merger with Battle Mountain Genetics, Inc. On October 17, 2016, the Company entered into an Agreement whereby the Company acquired 100% of Battle Mountain Genetics, Inc, in exchange for 50,000,000 shares of Sunset Island Group common stock. Immediately prior to the reverse merger, there were 30,894 common shares outstanding and no shares of Preferred shares outstanding. After the reverse merger, the Company had 50,031,771 Common shares outstanding and no shares of Preferred shares outstanding. Battle Mountain Genetics was incorporated in the State of California on September 29, 2016. Battle Mountain Genetics, Inc. was the surviving Company and became a wholly owned subsidiary of Sunset Island Group. Sunset Island Group had no operations, assets or liabilities prior to the reverse merger. The financial statements reflected in this 10-K as of October 31, 2016, represents the period September 29, 2016 (date of inception) to October 31, 2016.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Oct. 31, 2017
Notes to Financial Statements
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	Basis of Presentation The financial statements and related disclosures have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The financial statements have been prepared using the accrual basis of accounting in accordance with Generally Accepted Accounting Principles of the United States (“GAAP”). Consolidation Policy The audited consolidated financial statements of the Company include the accounts of the Company and its wholly owned subsidiary, Battle Mountain Genetics, Inc. All significant intercompany balances and transactions have been eliminated in consolidation. Use of Estimates and Assumptions The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Cash and cash equivalents Cash equivalents are short-term highly liquid investments that are readily convertible to cash with original maturities of three months or less, at the date acquired. As of October 31, 2017, and 2016, cash primarily consists of cash in bank. As of October 31, 2017 and 2016, cash was $24,656 and $970, respectively. Basic and Diluted Net Loss Per Share of Common Stock The Company has adopted ASC Topic 260, “Earnings per Share,” As at October 31, 2017, the Company has potentially 46,000,000 in dilutive securities, from outstanding Series A convertible preferred stock, which were excluded from the computation of diluted net loss per common share as the result of the computation was anti-dilutive. Concentrations of Credit Risk The Company’s financial instruments that are exposed to concentrations of credit risk primarily consist of its cash and cash equivalents and related party payables that it will likely incur in the near future. The Company places its cash and cash equivalents with financial institutions of high credit worthiness. At times, its cash and cash equivalents with a particular financial institution may exceed any applicable government insurance limits. The Company’s management plans to assess the financial strength and credit worthiness of any parties to which it extends funds, and as such, it believes that any associated credit risk exposures are limited. Financial Instruments The Company follows ASC 820, “ Fair Value Measurements and Disclosures, Level 1 Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities. Level 2 Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data. Level 3 Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities. Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of October 31, 2017. The carrying values of our financial instruments, including, cash and cash equivalents, accounts payable and accrued expenses; and dividend payable and due to related party approximate their fair values due to the short-term maturities of these financial instruments. Related Parties The Company follows ASC 850, “Related Party Disclosures,” Income Taxes We account for income taxes under ASC 740 “ Income Taxes Revenue Recognition The Company recognizes revenue in accordance with “Revenue from Contracts with Customers” (“ASC 606”). ASC 606 requires that the criteria must be met before revenue can be recognized: 1. The parties to the contract have approved the contract (in writing, orally, or in accordance with other customary business practices) and are committed to perform their respective obligations. 2. The Company can identify each party’s rights regarding the goods or services to be transferred. 3. The Company can identify the payment terms for the goods or services to be transferred. 4. The contract has commercial substance (that is, the risk, timing, or amount of the entity’s future cash flows is expected to change as a result of the contract). 5. It is probable that the Company will collect substantially all of the consideration to which it will be entitled in exchange for the goods or services that will be transferred to the customer. In evaluating whether collectability of an amount of consideration is probable, an entity shall consider only the customer’s ability and intention to pay that amount of consideration when it is due. The amount of consideration to which the entity will be entitled may be less than the price stated in the contract if the consideration is variable because the entity may offer the customer a price concession. Research and Development Expenses We follow ASC 730, “Research and Development,” Recently Issued Accounting Standards In June 2018, the FASB issued ASU 2018-07, Compensation-Stock Compensation (Topic 718), Improvements to Nonemployee Share-based Payments (“ASU 2018-07”). This ASU expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. The effective date for the standard is for interim periods in fiscal years beginning after December 15, 2018, with early adoption permitted, but no earlier than the Company's adoption date of Topic 606. Under the new guidance, the measurement of nonemployee equity awards is fixed on the grant date. The new guidance is required to be applied retrospectively with the cumulative effect recognized at the date of initial application. The Company is currently evaluating the effect ASU 2018-07 will have on the consolidated financial statements. In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement. The ASU modifies the disclosure requirements in Topic 820, Fair Value Measurement, by removing certain disclosure requirements related to the fair value hierarchy, modifying existing disclosure requirements related to measurement uncertainty and adding new disclosure requirements, such as disclosing the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period and disclosing the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. This ASU is effective for public companies for annual reporting periods and interim periods within those annual periods beginning after December 15, 2019. The Company is currently evaluating the effect, if any, that the ASU will have on its consolidated financial statements. In September 2017, the FASB has issued Accounting Standards Update (ASU) No. 2017-13, “Revenue Recognition (Topic 605), Revenue from Contracts with Customers (Topic 606), Leases (Topic 840), and Leases (Topic 842): Amendments to SEC Paragraphs Pursuant to the Staff Announcement at the July 20, 2017 EITF Meeting and Rescission of Prior SEC Staff Announcements and Observer Comments.” In May 2014, the FASB issued some accounting standards update which modifies the requirements for identifying, allocating, and recognizing revenue related to the achievement of performance conditions under contracts with customers. This update also requires additional disclosure related to the nature, amount, timing, and uncertainty of revenue that is recognized under contracts with customers. This guidance is effective for fiscal and interim periods beginning after December 15, 2017 and is required to be applied retrospectively to all revenue arrangements. The adoption of this guidance is not expected to have a significant impact on the Company’s consolidated financial statements. In February 2017, the FASB has issued Accounting Standards Update (ASU) No. 2017-05, “Other Income - Gains and Losses from the Derecognition of Nonfinancial Assets (Subtopic 610-20): Clarifying the Scope of Asset Derecognition Guidance and Accounting for Partial Sales of Nonfinancial Assets.” In January 2017, the FASB has issued Accounting Standards Update (ASU) No. 2017-04, “Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment.” In January 2017, the FASB issued ASU No. 2017-01, “Business Combinations (Topic 805): Clarifying the Definition of a Business.” Management has considered all recent accounting pronouncements issued. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s financial statements.

GOING CONCERN

GOING CONCERN	12 Months Ended
	Oct. 31, 2017
Notes to Financial Statements
NOTE 3 - GOING CONCERN	The Company’s financial statements have been prepared in conformity with GAAP, which contemplates the Company’s continuation as a going concern. The Company incurred operating losses of $690,688 during the year ended October 31, 2017 and has an accumulated deficit of $751,390 as of October 31, 2017. There are no assurances that the Company will be able to either (1) achieve a level of revenues adequate to generate sufficient cash flow from operations; or (2) obtain additional financing through either private placement, public offerings and/or bank financing necessary to support its working capital requirements. To the extent that funds generated from operations and any private placements, public offerings and/or bank financing are insufficient, the Company will have to raise additional working capital. No assurance can be given that additional financing will be available, or if available, will be on terms acceptable to the Company. If adequate working capital is not available to the Company, it may be required to curtail or cease its operations. Due to uncertainties related to these matters, there exists a substantial doubt about the ability of the Company to continue as a going concern. The accompanying unaudited interim financial statements do not include any adjustments related to the recoverability or classification of asset-carrying amounts or the amounts and classification of liabilities that may result should the Company be unable to continue as a going concern.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	12 Months Ended
	Oct. 31, 2017
Notes to Financial Statements
NOTE 4 - RELATED PARTY TRANSACTIONS	Note Payable During the year ended October 31, 2017, the Company issued various 5% notes to Novus Group, for gross proceeds of $363,200. The notes are due on December 31, 2018 or December 31, 2019. The notes accrue interest at 0% for the initial nine months and then 5% on annual rate thereafter. During the year ended October 31, 2017, the Company repaid $33,000. As of October 31, 2017 and 2016, the notes payable was $330,200 and $0, respectfully. During the year ended October 31, 2017 and period ended October 31, 2016, the notes payable incurred no interest expense. Due to Related Party During the year ended October 31, 2017, the Company received advances from an officer of the Company at the amount of $7,173 and repaid to her at $4,288. The loans are due on demand and non-interest bearing. As of October 31, 2017 and 2016, due to the officer was $1,885 and $0, respectively. Management Fees During the year ended October 31, 2017 and 2016, the Company recorded management fees of $38,168 and $0, respectively.

DIVIDEND PAYABLE

DIVIDEND PAYABLE	12 Months Ended
	Oct. 31, 2017
Notes to Financial Statements
NOTE 5 - DIVIDEND PAYABLE	On August 30, 2017, the Company filed with FINRA its corporate notice for the cash dividend. The record date for the dividend was September 15, 2017 at a rate of $0.001 per share with payment date of September 25, 2017. During the year ended October 31, 2017, the Company declared dividend at $50,672 and distributed cash dividend at $4,643. As of October 31, 2017, the dividend payable was $46,029.

STOCKHOLDERS' EQUITY

STOCKHOLDERS' EQUITY	12 Months Ended
	Oct. 31, 2017
Notes to Financial Statements
NOTE 6 - STOCKHOLDERS' EQUITY	The Company filed Amended and Restated Articles of Incorporation with the Secretary of State of the State of Colorado, as follows: · Effective November 19, 2018, the Company designated 500,000 shares of Series C Preferred Stock. · Effective March 14, 2018, the Company reduced the total number of authorized shares of stock of the Company to 42,000,000 shares. The total number of authorized shares of the Company is currently 15,000,000 shares of preferred stock and 27,000,000 shares of Common Stock. · Effective September 7, 2017, the Company designated 8,000,000 shares of its Series B Preferred Stock. · Effective August 20, 2017, the Company amended the designated shares of Series A Preferred Stock to 4,600,000 shares. Preferred Stock The Company has authorized 15,000,000 preferred shares with a par value of $0.0001 per share. The Board of Directors is authorized to divide the authorized shares of Preferred Stock into one or more series, each of which shall be so designated as to distinguish the shares thereof from the shares of all other series and classes. Series A Preferred Stock The Company has designated 4,600,000 shares of Series A Convertible Preferred Stock. The Series A Preferred Stock may convert into Common Stock at a rate equal to 10 shares of common stock for each share of Series A Preferred stock. In the event that any cash dividend on the Common Stock is declared by the Board, the Board shall simultaneously declare a dividend for each share of Series A Preferred Stock in an amount equal to the product of (i) the per share dividend declared and to be paid in respect of each share of Common Stock and (ii) the amount of common stock the Series A Preferred Stock is convertible into under the designation. On August 31, 2017, the Company finalized the cancelation of the 46,000,000 shares of common stock and issued 4,600,000 shares of its Series A Preferred Stock to its officers. As at October 31, 2017 and 2016, the Company had 4,600,000 and 0 shares of Series A Preferred Stock issued and outstanding, respectively. Series B Preferred Stock The Company has designated 8,000,000 shares of Series B Preferred Stock, with a face value of $1.00 per share. The Series B Preferred Stock has no conversion right or no voting rights. The shareholders of the Series B Preferred will be entitled to $200 per pound that the Company harvested from its cultivation operations, which is divided by the outstanding shares of the Series B preferred shares. As at October 31, 2017 and 2016, the Company had no shares of Series B Preferred Stock issued and outstanding. Series C Preferred Stock The Company has designated 500,000 shares of Series C Convertible Preferred Stock. The Series C Preferred Stock has no voting rights. The Series C Preferred Stock may convert into Common Stock at a rate equal to 10 shares of common stock for each share of Series C Preferred stock. In the event that any cash dividend on the Common Stock is declared by the Board, the Board shall simultaneously declare a dividend for each share of Series C Preferred Stock in an amount equal to the product of (i) the per share dividend declared and to be paid in respect of each share of Common Stock and (ii) the amount of common stock the Series C Preferred Stock is convertible into under the designation. As at October 31, 2017 and 2016, the Company had no shares of Series C Preferred Stock issued and outstanding. Common Stock The Company has authorized 27,000,000 common shares with a par value of $0.0001 per share. Each common share entitles the holder to one vote, in person or proxy, on any matter on which action of the stockholders of the corporation is sought. During the year ended October 31, 2017 and 2016, the Company issued 1,340,000 and 4,000,000 common shares for proceeds of $134,000 and $11,000, respectively. During the year ended October 31, 2017, the founders exchanged an aggregate of 46,000,000 shares of common stock for 4,600,000 shares of Series A Preferred stock. As at October 31, 2017 and 2016, the Com pany had 4,871,771 and Additional paid in capital During the year ended October 31, 2017, the Company’s officer contributed additional paid in capital in the amount of $240,115. Subscriptions Received On October 30, 2017, the Company received cash of $50,000 for the stock subscription at $0.10 per share and recorded this as subscriptions received – shares to be issued as of October 31, 2017. On November 1, 2017, 500,000 shares of common stock were issued.

PROVISION FOR INCOME TAXES

PROVISION FOR INCOME TAXES	12 Months Ended
	Oct. 31, 2017
Notes to Financial Statements
NOTE 7 - PROVISION FOR INCOME TAXES	The Company provides for income taxes under ASC 740, “ Income Taxes.” On December 22, 2017, the United States enacted the Tax Cuts and Jobs Act (the “Act”) resulting in significant modifications to existing law. The Company’s financial statements for the years ended October 31, 2017 and period ended October 31, 2016, reflect certain effects of the Act which includes a reduction in the corporate tax rate from 34% to 21% as well as other changes. The components of the Company’s deferred tax asset and reconciliation of income taxes computed at the statutory rate to the income tax amount recorded as of October 31, 2017 and 2016 are as follows: October 31, October 31, 2017 2016 Net Operating loss carryforward $ 751,390 $ 10,030 Effective tax rate 21 % 21 % Deferred tax asset 157,792 2,106 Less: valuation allowance (157,792 ) (2,106 ) Net deferred tax asset $ - $ - As of October 31, 2017, utilization of the NOL carry forwards, which will begin to expire between 2031 and 2037, of approximately $700,718 for federal income tax reporting purposes, may be subject to an annual limitation due to ownership change limitations that may have occurred or that could occur in the future, as required by Section 382 of the Internal Revenue Code of 1986, as amended (the “Code”). These ownership changes may limit the amount of the NOL carry forwards that can be utilized annually to offset future taxable income and tax, respectively. In general, an “ownership change” as defined by Section 382 of the Code results from a transaction or series of transactions over a three-year period resulting in an ownership change of more than 50 percentage points of the outstanding stock of a company by certain stockholders. Tax returns for the years ended 2011 through 2017 are subject to review by the tax authorities.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	12 Months Ended
	Oct. 31, 2017
Notes to Financial Statements
Note 8 - COMMITMENTS AND CONTINGENCIES	On March 1, 2017, the Company executed a lease for 12,000 square feet green house space and 1,000 square of warehouse space expiring March 31, 2020. The monthly lease is a base amount of $7,000 per month, plus maintenance and improvement fees prorated for the Company’s portion of leased property as shared with other tenants and property owner. During the year ended October 31, 2017 and period ended October 31, 2016, we incurred total lease expenses of $89,622 and $0, respectively. The Company has aggregate future minimum lease commitments as of October 31, 2017, as follows: Year ending October 31, 2018 $ 84,000 2019 84,000 2020 35,000 Total $ 203,000

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	12 Months Ended
	Oct. 31, 2017
Notes to Financial Statements
NOTE 9 - SUBSEQUENT EVENTS	Subsequent to October 31, 2017 and through the date that these financials were approved to be issued, the Company had the following subsequent events: On January 16, 2018, the Company issued a convertible promissory note at $220,000 principal amount. The note is repayable in six months and bears interest at 12% per annum. The note is convertible into common shares at the option of the holder at issuance based on the discounted (50% discount) lowest trading prices of the Company’s shares during 25 days prior to the conversion. On February 20, 2018, Auctus Fund was repaid for the loan and as such it is no longer outstanding and has been retired. The Company had the right to prepay the note at 135% nut negotiated the rate down to 125% plus 15,000 shares of restricted stock. The repayment amount was $276,627 plus 15,000 shares of restricted stock. On February 14, 2018, the Company has executed an agreement with St George Investments for $4,245,000 with the initial tranche being $850,000. This note carries an original issuance discount of $385,000 and the Company agreed to pay financing fees of $10,000. The note is repayable in one year and bears interest at 10% per annum. The note is convertible into common shares after six months from the issuance based on the discounted (50% discount) lowest trading prices of the Company’s shares during 25 days prior to the conversion. This Note shall be comprised of thirteen (13) tranches (each, a “ Tranche Initial Tranche Subsequent Tranche On February 20, 2018, the Company received the first tranche. As part of the initial tranche the Company repaid Auctus Fund. On February 26, 2018, the Company’s Board of Directors approved a cash dividend. The record date for the dividend is March 31, 2018 at a rate of $0.001 per share. On March 2, 2018. the Company has agreed to terms with REI Extracts regarding an extraction and distribution joint venture. Equipment has been ordered and is being shipped to the Company’s location in Salinas, California. The operations of the joint venture will be conducted under the Company’s licenses. Additionally, the Company has retained REI Extracts to provide consulting services related to cultivation and to provide a master grower. The new master grower has been working with the Company since January 2018. The grower will be paid based on the yield of sellable flower per bay. The incentive pay shall be paid as follows: Harvested pounds per bay of sellable flower Incentive Bonus 0-40 $0 40-60 $40 per pound in excess of 40 pounds 60-80 $70 per pound in excess of 40 pounds 80-100 $100 per pound in excess of 40 pounds 100+ $120 per pound in excess of 40 pounds On November 30, 2018, the Company sold 333,000 shares of Series C Preferred Stock to Job Growing Inc. (“Job Growing”) for 50% of the profits of Job Growing. In the event that Job Growing either: (i) files a Registration Statement to become a reporting company under the Securities Exchange Act of 1934 which becomes effective, or (ii) is acquired by an unrelated third party, then Sunset Island Group has the right to buy a Fifty Percent (50%) equity interest in the Job Growing for One Dollar ($1.00).

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Oct. 31, 2017
Summary Of Significant Accounting Policies
Basis of Presentation	The financial statements and related disclosures have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The financial statements have been prepared using the accrual basis of accounting in accordance with Generally Accepted Accounting Principles of the United States (“GAAP”).
Consolidation Policy	The audited consolidated financial statements of the Company include the accounts of the Company and its wholly owned subsidiary, Battle Mountain Genetics, Inc. All significant intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates and Assumptions	The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Cash and cash equivalents	Cash equivalents are short-term highly liquid investments that are readily convertible to cash with original maturities of three months or less, at the date acquired. As of October 31, 2017, and 2016, cash primarily consists of cash in bank. As of October 31, 2017 and 2016, cash was $24,656 and $970, respectively.
Basic and Diluted Net Loss Per Share of Common Stock	The Company has adopted ASC Topic 260, “Earnings per Share,” As at October 31, 2017, the Company has potentially 46,000,000 in dilutive securities, from outstanding Series A convertible preferred stock, which were excluded from the computation of diluted net loss per common share as the result of the computation was anti-dilutive.
Concentrations of Credit Risk	The Company’s financial instruments that are exposed to concentrations of credit risk primarily consist of its cash and cash equivalents and related party payables that it will likely incur in the near future. The Company places its cash and cash equivalents with financial institutions of high credit worthiness. At times, its cash and cash equivalents with a particular financial institution may exceed any applicable government insurance limits. The Company’s management plans to assess the financial strength and credit worthiness of any parties to which it extends funds, and as such, it believes that any associated credit risk exposures are limited.
Financial Instruments	The Company follows ASC 820, “ Fair Value Measurements and Disclosures, Level 1 Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities. Level 2 Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data. Level 3 Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities. Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of October 31, 2017. The carrying values of our financial instruments, including, cash and cash equivalents, accounts payable and accrued expenses; and dividend payable and due to related party approximate their fair values due to the short-term maturities of these financial instruments.
Related Parties	The Company follows ASC 850, “Related Party Disclosures,”
Income Taxes	We account for income taxes under ASC 740 “ Income Taxes
Revenue recognition	The Company recognizes revenue in accordance with “Revenue from Contracts with Customers” (“ASC 606”). ASC 606 requires that the criteria must be met before revenue can be recognized: 1. The parties to the contract have approved the contract (in writing, orally, or in accordance with other customary business practices) and are committed to perform their respective obligations. 2. The Company can identify each party’s rights regarding the goods or services to be transferred. 3. The Company can identify the payment terms for the goods or services to be transferred. 4. The contract has commercial substance (that is, the risk, timing, or amount of the entity’s future cash flows is expected to change as a result of the contract). 5. It is probable that the Company will collect substantially all of the consideration to which it will be entitled in exchange for the goods or services that will be transferred to the customer. In evaluating whether collectability of an amount of consideration is probable, an entity shall consider only the customer’s ability and intention to pay that amount of consideration when it is due. The amount of consideration to which the entity will be entitled may be less than the price stated in the contract if the consideration is variable because the entity may offer the customer a price concession.
Research and Development Expenses	We follow ASC 730, “Research and Development,”
Recently Issued Accounting Standards	In June 2018, the FASB issued ASU 2018-07, Compensation-Stock Compensation (Topic 718), Improvements to Nonemployee Share-based Payments (“ASU 2018-07”). This ASU expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. The effective date for the standard is for interim periods in fiscal years beginning after December 15, 2018, with early adoption permitted, but no earlier than the Company's adoption date of Topic 606. Under the new guidance, the measurement of nonemployee equity awards is fixed on the grant date. The new guidance is required to be applied retrospectively with the cumulative effect recognized at the date of initial application. The Company is currently evaluating the effect ASU 2018-07 will have on the consolidated financial statements. In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement. The ASU modifies the disclosure requirements in Topic 820, Fair Value Measurement, by removing certain disclosure requirements related to the fair value hierarchy, modifying existing disclosure requirements related to measurement uncertainty and adding new disclosure requirements, such as disclosing the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period and disclosing the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. This ASU is effective for public companies for annual reporting periods and interim periods within those annual periods beginning after December 15, 2019. The Company is currently evaluating the effect, if any, that the ASU will have on its consolidated financial statements. In September 2017, the FASB has issued Accounting Standards Update (ASU) No. 2017-13, “Revenue Recognition (Topic 605), Revenue from Contracts with Customers (Topic 606), Leases (Topic 840), and Leases (Topic 842): Amendments to SEC Paragraphs Pursuant to the Staff Announcement at the July 20, 2017 EITF Meeting and Rescission of Prior SEC Staff Announcements and Observer Comments.” In May 2014, the FASB issued some accounting standards update which modifies the requirements for identifying, allocating, and recognizing revenue related to the achievement of performance conditions under contracts with customers. This update also requires additional disclosure related to the nature, amount, timing, and uncertainty of revenue that is recognized under contracts with customers. This guidance is effective for fiscal and interim periods beginning after December 15, 2017 and is required to be applied retrospectively to all revenue arrangements. The adoption of this guidance is not expected to have a significant impact on the Company’s consolidated financial statements. In February 2017, the FASB has issued Accounting Standards Update (ASU) No. 2017-05, “Other Income - Gains and Losses from the Derecognition of Nonfinancial Assets (Subtopic 610-20): Clarifying the Scope of Asset Derecognition Guidance and Accounting for Partial Sales of Nonfinancial Assets.” In January 2017, the FASB has issued Accounting Standards Update (ASU) No. 2017-04, “Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment.” In January 2017, the FASB issued ASU No. 2017-01, “Business Combinations (Topic 805): Clarifying the Definition of a Business.” Management has considered all recent accounting pronouncements issued. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s financial statements.

PROVISION FOR INCOME TAXES (Tab

PROVISION FOR INCOME TAXES (Tables)	12 Months Ended
	Oct. 31, 2017
Provision For Income Taxes
Schedule of deferred tax asset	October 31, October 31, 2017 2016 Net Operating loss carryforward $ 751,390 $ 10,030 Effective tax rate 21 % 21 % Deferred tax asset 157,792 2,106 Less: valuation allowance (157,792 ) (2,106 ) Net deferred tax asset $ - $ -

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Tables)	12 Months Ended
	Oct. 31, 2017
Commitments And Contingencies
Future minimum lease	Year ending October 31, 2018 $ 84,000 2019 84,000 2020 35,000 Total $ 203,000

SUBSEQUENT EVENTS (Tables)

SUBSEQUENT EVENTS (Tables)	12 Months Ended
	Oct. 31, 2017
Subsequent Events
Summary of incentive payments	Harvested pounds per bay of sellable flower Incentive Bonus 0-40 $0 40-60 $40 per pound in excess of 40 pounds 60-80 $70 per pound in excess of 40 pounds 80-100 $100 per pound in excess of 40 pounds 100+ Summa

DESCRIPTION OF BUSINESS (Detail

DESCRIPTION OF BUSINESS (Details Narrative)	1 Months Ended	12 Months Ended
	Oct. 17, 2016shares	Oct. 31, 2017ft²shares	Oct. 31, 2016shares
Common Stock, shares outstanding		4,871,771	50,031,771
Description for operating space		The greenhouse is 12,000 square feet; however, the Company is currently operating on approximately 22,000 square feet. This includes the 12,000 square feet of greenhouse space which 10,000 square feet is used for cultivation and 2,000 us used as staging area for planting and harvesting
Description for expansion of operating space		The Company is currently looking to expand to approximately 154,000 and has been in discussions with or current landlord about expanding to 154,000
Space owned by landlord | ft²		750,000
Description for space acquisition		The Company has agreed to acquire 6,000 square feet of a neighbor's greenhouse and expects that the agreement to be in place October 1, 2017. The Company is currently in discussions to acquire the neighbors entire 34,000 and is looking an additional 100,000 square feet that is close to the current operations
Battle mountain genetics Inc [member]
Acquisition of entity, percentage	100.00%
Common stock issued for acquisition	50,000,000
Country or state of incorporation		California
Date of incorporation		Sep. 29, 2016
Prior to reverse merger [member]
Common Stock, shares outstanding	30,894
Preferred Stock, share outstanding	0
After reverse merger [member]
Common Stock, shares outstanding	50,031,771
Preferred Stock, share outstanding	0

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	12 Months Ended
	Oct. 31, 2017	Oct. 31, 2016
Disclosure Summary Of Significant Accounting Policies Details Narrative Abstract
Cash	$ 24,656	$ 970
Anti dilutive securities excluded from the computation of EPS	46,000,000

GOING CONCERN (Details Narrativ

GOING CONCERN (Details Narrative) - USD ($)	1 Months Ended	12 Months Ended
	Oct. 31, 2016	Oct. 31, 2017
Going Concern
Loss from operations	$ (10,030)	$ (690,688)
Accumulated deficit	$ (10,030)	$ (751,390)

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)	1 Months Ended	12 Months Ended
	Oct. 31, 2016	Oct. 31, 2017
Proceeds from notes payable		$ 363,200
Notes payable (Related Party)		330,200
Proceeds from related party		7,173
Repayment to related party		4,288
Officer payroll		38,168
Officer [Member]
Proceeds from related party		7,173
Repayment to related party		(4,288)
Due to related party	$ 0	$ 1,885
Novus Group [Member]
Notes payabe interest rate		5.00%
Proceeds from notes payable		$ 363,200
Description of maturity date		December 31, 2018 or December 31, 2019
Description of accrued interest rate		The notes accrue interest at 0% for the initial nine months and then 5% on annual rate thereafter
Repayments of notes payable		$ 33,000

DIVIDEND PAYABLE (Details Narra

DIVIDEND PAYABLE (Details Narrative) - USD ($)	1 Months Ended		12 Months Ended
	Aug. 30, 2017	Oct. 31, 2016	Oct. 31, 2017
Declaration of cash dividend			$ (50,672)
Dividends paid			(4,643)
Dividend payable			$ 46,029
FINRA [Member]
Dividend record date	Sep. 15, 2017
Rate of dividend	$ 0.001
Dividend payment date	Sep. 25, 2017

STOCKHOLDERS' EQUITY (Details N

STOCKHOLDERS' EQUITY (Details Narrative) - USD ($)	1 Months Ended		12 Months Ended
	Aug. 31, 2017	Oct. 31, 2016	Oct. 31, 2017	Oct. 31, 2016	Nov. 19, 2018	Mar. 14, 2018	Nov. 01, 2017	Sep. 07, 2017	Aug. 20, 2017
Preferred stock, shares authorized		15,000,000	15,000,000	15,000,000
Preferred stock, par value		$ 0.0001	$ 0.0001	$ 0.0001
Common stock, shares authorized		500,000,000	27,000,000	500,000,000
Common stock, par value		$ 0.0001	$ 0.0001	$ 0.0001
Common stock, shares issued		50,031,771	4,871,771	50,031,771			500,000
Common stock, shares outstanding		50,031,771	4,871,771	50,031,771
Common stock shares issued during the period			1,340,000	4,000,000
Proceeds from issuance of common shares			$ 134,000	$ 11,000
Contribution to capital			$ 240,115
Subscriptions received - shares to be issued, price per share			$ 0.10
Subscriptions received - shares to be issued			$ 50,000
Subsequent Event [Member]
Total authorized capital						42,000,000
Series A Preferred Stock
Preferred stock, shares authorized		4,600,000	4,600,000	4,600,000					4,600,000
Preferred stock, issued		0	4,600,000	0
Preferred stock, outstanding		0	4,600,000	0
Convertible preferred stock, conversion terms			Series A Preferred Stock may convert into Common Stock at a rate equal to 10 shares of common stock for each share of Series A Preferred stock
Series A Preferred Stock | Founder [Member]
Shares issued description			The founders exchanged an aggregate of 46,000,000 shares of common stock for 4,600,000 shares of Series A Preferred stock.
Series A Preferred Stock | Officer [Member]
Shares issued description	The Company finalized the cancelation of the 46,000,000 shares of common stock and issued 4,600,000 shares of its Series A Preferred Stock to its officers.
Series C Preferred Stock [Member]
Preferred stock, shares authorized		500,000	500,000	500,000
Preferred stock, issued		0	0	0
Preferred stock, outstanding		0	0	0
Convertible preferred stock, conversion terms			The Series C Preferred Stock has no voting rights.
Preferred stock, redemption terms			The Series C Preferred Stock may convert into Common Stock at a rate equal to 10 shares of common stock for each share of Series C Preferred stock.
Series C Preferred Stock [Member] | Subsequent Event [Member]
Preferred stock, shares authorized					500,000
Series B Preferred Stock [Member]
Preferred stock, shares authorized		8,000,000	8,000,000	8,000,000				8,000,000
Preferred stock, issued		0	0	0
Preferred stock, outstanding		0	0	0
Convertible preferred stock, conversion terms			The Series B Preferred Stock has no conversion right or no voting rights
Preferred stock, redemption terms			The shareholders of the Series B Preferred will be entitled to $200 per pound that is sold by the Company which is divided by the outstanding shares of the Series B Preferred

PROVISION FOR INCOME TAXES (Det

PROVISION FOR INCOME TAXES (Details) - USD ($)	12 Months Ended
	Oct. 31, 2017	Oct. 31, 2016
Provision For Income Taxes Details Abstract
Net Operating loss carryforward	$ 751,390	$ 10,030
Effective tax rate	21.00%	21.00%
Deferred tax asset	$ 157,792	$ 2,106
Less: valuation allowance	(157,792)	(2,106)
Net deferred tax asset

PROVISION FOR INCOME TAXES (D_2

PROVISION FOR INCOME TAXES (Details Narrative)	12 Months Ended
	Oct. 31, 2017USD ($)
Provision For Income Taxes Details Abstract
Net operating loss carryforward expiration date	between 2031 and 2037
Utilization of the NOL carry forwards	$ 700,718

COMMITMENTS AND CONTINGENCIES_2

COMMITMENTS AND CONTINGENCIES (Details)	Oct. 31, 2017USD ($)
Disclosure Commitments And Contingencies Details Abstract
2018	$ 84,000
2019	84,000
2020	35,000
Total	$ 203,000

COMMITMENTS AND CONTINGENCIES_3

COMMITMENTS AND CONTINGENCIES (Details Narrative)	1 Months Ended	12 Months Ended
	Oct. 31, 2016USD ($)	Oct. 31, 2017USD ($)ft²	Oct. 31, 2016USD ($)
Disclosure Commitments And Contingencies Details Narrative Abstract
Monthly lease payments		$ 7,000
Description for warehouse space lease term		1,000 square of warehouse space expiring March 31, 2020
Operating lease expiration date		Mar. 31, 2020
Area of greenhouse space leased | ft²		12,000
Lease expenses		$ 89,622	$ 0

SUBSEQUENT EVENTS (Details)

SUBSEQUENT EVENTS (Details) - Subsequent Event [Member]	Mar. 02, 2018
0-40 [Member]
Harvested pounds per bay of sellable flower	0-40
Incentive Bonus	$0
40-60 [Member]
Harvested pounds per bay of sellable flower	40-60
Incentive Bonus	$40 per pound in excess of 40 pounds
60-80 [Member]
Harvested pounds per bay of sellable flower	60-80
Incentive Bonus	$70 per pound in excess of 40 pounds
80-100 [Member]
Harvested pounds per bay of sellable flower	80-100
Incentive Bonus	$100 per pound in excess of 40 pounds
100+ [Member]
Harvested pounds per bay of sellable flower	100+
Incentive Bonus	$120 per pound in excess of 40 pounds

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative)	1 Months Ended
	Nov. 30, 2018shares	Feb. 26, 2018$ / shares	Feb. 20, 2018USD ($)shares	Feb. 14, 2018USD ($)Integer	Jan. 16, 2018USD ($)	Oct. 31, 2017shares	Oct. 31, 2016shares
Series C Preferred Stock [Member]
Preferred Stock, shares issued | shares						0	0
Subsequent Event [Member] | Convertible Promissory Note [Member]
Debt conversion converted amount, principal					$ 220,000
Convertible promissory note, interest rate					12.00%
Debt conversion, description					The note is convertible into common shares at the option of the holder at issuance based on the discounted (50% discount) lowest trading prices of the Company’s shares during 25 days prior to the conversion.
Subsequent Event [Member] | Subsequent Tranche [Member]
Description of tranche				This Note shall be comprised of thirteen (13) tranches (each, a “Tranche”), consisting of (i) an initial Tranche in an amount equal to $945,000.00 and any interest, costs, fees or charges accrued thereon or added thereto under the terms of this Note and the other Transaction Documents (as defined in the Purchase Agreement) (the “Initial Tranche”), and (ii) twelve (12) additional Tranches, each in the amount of $275,000.00, plus any interest, costs, fees or charges accrued thereon or added thereto under the terms of this Note and the other Transaction Documents (each, a “Subsequent Tranche”).
Subsequent Event [Member] | Initial Tranche [Member]
Initial cash purchase price				$ 85,000
Subsequent Event [Member] | Tranche Two [Member]
Initial amount				$ 275,000
Number of tranches | Integer				12
Subsequent Event [Member] | Tranche One [Member]
Initial amount				$ 945,000
Number of tranches | Integer				13
Subsequent Event [Member] | Tranche [Member]
Initial amount				$ 850,000
Subsequent Event [Member] | Job Growing Inc [Member] | Series C Preferred Stock [Member]
Preferred Stock, shares issued | shares	333,000
Subsequent Event [Member] | Board of Directors [Member]
Rate of dividend | $ / shares		$ 0.001
Dividend record date		Mar. 31, 2018
Subsequent Event [Member] | Unrelated Third Party [Member] | Job Growing Inc [Member]
Description of equity interest	Fifty Percent (50%) equity interest in the Job Growing for One Dollar ($1.00).
Subsequent Event [Member] | Auctus Fund [Member]
Restricted shares issued | shares			15,000
Restricted shares value			$ 276,627
Description of restricted shares			The Company had the right to prepay the note at 135% nut negotiated the rate down to 125% plus 15,000 shares of restricted stock.
Subsequent Event [Member] | St George [Member]
Convertible promissory note, interest rate				10.00%
Debt conversion, description				The note is convertible into common shares after six months from the issuance based on the discounted (50% discount) lowest trading prices of the Company’s shares during 25 days prior to the conversion.
Investments				$ 4,245,000
Original issuance discount				385,000
Payment for financing fees				$ 10,000